$Neuronetics (STIM.US)$ NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting Neuronetics announced its participation in the 12th Annual Clinical TMS Society (CTMSS) Meeting in London from June 13-15, 2024. They will present six posters and one oral presentation showcasing data from the NeuroStar TMS System. Highlights include early prediction of nonresponse in major depressive disorder, the impact of treatment timing, efficacy of accelerated TMS protocols, effect...
Neuronetics股票討論區
醫療保健服務機構為青少年新增第一線TMS覆蓋範圍。納斯達克:STIM的Neuronetics公司宣布,醫療保健服務公司擴大了15歲以上患有重度抑鬱症(MDD)的青少年使用TMS(經結腦磁刺激)的訪問權限。此政策更新與美國食品藥品監督管理局最近核准的NeuroStar TMS療法作為這個年齡群體第一線附加治療一致。HCSC是美國最大的客戶擁有的健康保險公司...
3分鐘前,美東時間8:31 am
通過GLOBENEWSWIRE。
賓夕法尼亞州馬爾彬,2024年9月19日(全球新聞網)-- Neuronetics,Inc.(NASDAQ:STIMSTIM是一家醫療科技公司,專注於設計、開發和營銷改善患有神經健康障礙患者生活品質的產品。該公司宣布,更多付款人已更新其TMS(經顱磁刺激)醫療保險覆蓋範圍...
NeuroStar®發佈軟體升級,提升病患護理品質
Neuronetics(納斯達克:STIM)宣布了其NeuroStar愛文思控股療法和TrakStar®病患數據管理軟體的重大升級。這些增強功能著重於改善病患通信、精簡臨床數據捕獲,以及加強網絡安全概念。關鍵升級包括:
1. 加強病患通信:新增CRm功能,用於自動簡訊和電子郵件通信,安全保險...
Neuronetics和Greenbrook TMS宣布達成最終合併協議
Neuronetics(NASDAQ: STIM)和Greenbrook TMS(OTCMKTS: GBNHF)宣布達成一項全股票交易的最終合併協議。該合併旨在創建一家提供具有重大規模的TMS療法的垂直整合組織。主要好處包括:
1. 增加NeuroStar TMS的品牌知名度
2. 更一致的實施最佳實踐
3. 提升 neuronetics 所有股東的福利...
Neuronetics: Aetna Updated Tms Coverage to Include Adolescents Aged 15 and Older With
NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting
Neuronetics announced its participation in the 12th Annual Clinical TMS Society (CTMSS) Meeting in London from June 13-15, 2024. They will present six posters and one oral presentation showcasing data from the NeuroStar TMS System. Highlights include early prediction of nonresponse in major depressive disorder, the impact of treatment timing, efficacy of accelerated TMS protocols, effect...
暫無評論